Novo Nordisk | NVO - EPS Earnings Per Share


Novo Nordisk reported DKK1.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31
FY2023Q3 Sep/2023 5.00 0.68 6.34 Nov/02




Eps Change Date
ANI Pharmaceuticals USD 2.05 0.28 Mar/2026
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Bausch Health Companies USD 0.78 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Canopy Growth CAD -0.05 0.03 Dec/2025
Corcept Therapeutics USD -0.3 0.5 Mar/2026
Drreddys Laboratories INR 0.06 0.1 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Novo Nordisk DKK 1.02 0.01 Dec/2025
Pacira USD 0.6 0.54 Mar/2026
Perrigo USD 0.43 0.34 Mar/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026